维普中文期刊产品整合服务
14篇 您的检索式:作者名="Kilhovd B"
    题名 作者 年代 出处 被引量
1superior glycemic control weth repaglinide compared with glipizide in type 2 diabetes 显示文摘Madsbads kilhovd B Lager I 2000Diabetes2000,49,1:1
2Increased serum levels of advanced glycation end products predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow up study显示文摘Kilhovd B K Juutilainen A Lehto S 2007Diabetologia2007,50,7:1
3Tim course of specific AGEs during optimised glycaemic control in type 2 diabetes显示文摘MENTINK C J KILHOVD B K RONDAS-COLBERS G J 2006Neth J Med2006,64,1:1
4Repaglinide compared to glipizide in the treatment of type 2 diabetic patient显示文摘DEJGAARD A MADSBAD S KILHOVD B 1998Diadetologia1998,41,1:1
5Superior glycemic control with repaglinide compared with gl ipizide in type 2 diabetes显示文摘Madsbad S Kilhovd B Lager I 2008Diabetes2008,49,1:1
6Infarct size as estimated from pesk creatine kinase and lactale dehydrogenase is probably reduced in patients using calcium antagoists at the onset of symptoms显示文摘Landmark K Abdelnoor M Kilhovd B 0,,04:1
7Formation of ad- vanced glycation end products (AGEs)may participate in the development of coronary heart disease in patients with type 2 diabetes 显示文摘Kilhovd B Berg TJ Torjesen PA 1998Diabetologia1998,41,1:1
8Heterogeneity of non - insulin - dependent diabetes expressed as variability in insulin sensitivi- ty, beta - cell function and cardiovascular risk profile 显示文摘Birkel and KI Kilhovd B Thorsby P 2003Diabet Med2003,20,1:1
9Serum levels of advanced glycation end products are increased in patients with type I diabetes and coronary heart disease显示文摘Kilhovd B K Herg T J Birkeland K I 1999Diabetes Care1999,22,9:1
10Infarct size as esti mated from pesk creatine kinase and lactate dehydrogenase is probably reduced in patients using calcium antagoists at the onset of symptoms显示文摘Landmark K Abdelnoor M Kilhovd B 1997Cardiovasc Drugs Ther1997,11,4:1
11Eating fish may re- duce infarct size and the occurrence of Q wave infarcts 显示文摘Landmark K Abdelnoor M Kilhovd B 1998Eur J Clin Nutr1998,52,1:1
12Heterogeneity of non-insu- lin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profile 显示文摘Birkel KI Kilhovd B Thorsby P 2003Diabet Med2003,20,1:1
13Comparison betw- een repaglinide and glipizide in type 2 diabetes mellitus: a 1-year multicentre study显示文摘Madsbad S Kilhovd B Lager I 2001Diabet Med2001,18,5:1
14Infarct size as estimated from pesk creatine kinase and lactale dehydrogenase is probably reduced in patients using calcium antagoists at the onset of symptoms显示文摘Landmark K Abdelnoor M Kilhovd B 1997Carddiovasc Drugs Ther1997,11,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费